Five months later, semaglutide injections under the name ‘Wegovy’ were approved for use in the UK, followed by a similar drug, Mounjaro (tirzepatide), which was approved one month later. Following a recent price hike, users of Mounjaro will be expected to shell out £330 a month from September. Meanwhile, Ozempic shortages in the US have seen consumers face prices of $1,600 (£1,183) a month — and they’ve paid it.
